aluates Reports

$ 0.0

Automative

Global Liver Cancer Therapeutics Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-36H14019

Global Liver Cancer Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Liver Cancer Therapeutics Market Insights, Forecast to 2030

Code: QYRE-Auto-36H14019

Report

December 2024

Pages:113

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

ArQule Inc

Bayer

Bristol–Myers Squibb

CELSION

Eisai Co Ltd

Exelixis Inc

Roche

Merck

Pfizer Inc

IntegraGen

Liver Cancer Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Liver Cancer Therapeutics Market

Liver cancer, also known as hepatic cancer and primary hepatic cancer, is cancer that starts in the liver. Cancer which has spread from elsewhere to the liver, known as liver metastasis, is more common than that which starts in the liver. Symptoms of liver cancer may include a lump or pain in the right side below the rib cage, swelling of the abdomen, yellowish skin, easy bruising, weight loss, and weakness. The treatment of liver cancer patients is mainly determined by the organ involved, the tumor spread, the patient's general condition and age.

Market Analysis and Insights: Global Liver Cancer Therapeutics Market

The global Liver Cancer Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Liver Cancer Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Liver Cancer Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Liver Cancer Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liver Cancer Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Liver Cancer Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Liver Cancer Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Liver Cancer Therapeutics Market Report

Report Metric	Details
Report Name	Liver Cancer Therapeutics Market
CAGR	5%
Segment by Type	Targeted Therapy Radiation Therapy Immunotherapy Chemotherapy Other
Segment by Application	Hepatocellular Carcinoma Cholangio Carcinoma Hepatoblastoma Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ArQule, Bayer, Bristol-Myers Squibb, Celsion, Eisai, Exelixis, Roche, Merck, Pfizer, IntegraGen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Liver Cancer Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liver Cancer Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liver Cancer Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Liver Cancer Therapeutics Market report?

Ans: The main players in the Liver Cancer Therapeutics Market are ArQule, Bayer, Bristol-Myers Squibb, Celsion, Eisai, Exelixis, Roche, Merck, Pfizer, IntegraGen

What are the Application segmentation covered in the Liver Cancer Therapeutics Market report?

Ans: The Applications covered in the Liver Cancer Therapeutics Market report are Hepatocellular Carcinoma, Cholangio Carcinoma, Hepatoblastoma, Other

What are the Type segmentation covered in the Liver Cancer Therapeutics Market report?

Ans: The Types covered in the Liver Cancer Therapeutics Market report are Targeted Therapy, Radiation Therapy, Immunotherapy, Chemotherapy, Other

Recommended Reports

Liver-Related Diseases

Cancer Therapeutics

Cancer Therapy Innovations

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Liver Cancer Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Targeted Therapy

1.2.3 Radiation Therapy

1.2.4 Immunotherapy

1.2.5 Chemotherapy

1.2.6 Other

1.3 Market by Application

1.3.1 Global Liver Cancer Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hepatocellular Carcinoma

1.3.3 Cholangio Carcinoma

1.3.4 Hepatoblastoma

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Liver Cancer Therapeutics Market Perspective (2019-2030)

2.2 Global Liver Cancer Therapeutics Growth Trends by Region

2.2.1 Liver Cancer Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Liver Cancer Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Liver Cancer Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Liver Cancer Therapeutics Market Dynamics

2.3.1 Liver Cancer Therapeutics Industry Trends

2.3.2 Liver Cancer Therapeutics Market Drivers

2.3.3 Liver Cancer Therapeutics Market Challenges

2.3.4 Liver Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Liver Cancer Therapeutics by Players

3.1.1 Global Liver Cancer Therapeutics Revenue by Players (2019-2024)

3.1.2 Global Liver Cancer Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Liver Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Liver Cancer Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Liver Cancer Therapeutics Market Concentration Ratio

3.4.1 Global Liver Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Liver Cancer Therapeutics Revenue in 2023

3.5 Global Key Players of Liver Cancer Therapeutics Head office and Area Served

3.6 Global Key Players of Liver Cancer Therapeutics, Product and Application

3.7 Global Key Players of Liver Cancer Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Liver Cancer Therapeutics Breakdown Data by Type

4.1 Global Liver Cancer Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Liver Cancer Therapeutics Forecasted Market Size by Type (2025-2030)

5 Liver Cancer Therapeutics Breakdown Data by Application

5.1 Global Liver Cancer Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Liver Cancer Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Liver Cancer Therapeutics Market Size (2019-2030)

6.2 North America Liver Cancer Therapeutics Market Size by Type

6.2.1 North America Liver Cancer Therapeutics Market Size by Type (2019-2024)

6.2.2 North America Liver Cancer Therapeutics Market Size by Type (2025-2030)

6.2.3 North America Liver Cancer Therapeutics Market Share by Type (2019-2030)

6.3 North America Liver Cancer Therapeutics Market Size by Application

6.3.1 North America Liver Cancer Therapeutics Market Size by Application (2019-2024)

6.3.2 North America Liver Cancer Therapeutics Market Size by Application (2025-2030)

6.3.3 North America Liver Cancer Therapeutics Market Share by Application (2019-2030)

6.4 North America Liver Cancer Therapeutics Market Size by Country

6.4.1 North America Liver Cancer Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Liver Cancer Therapeutics Market Size by Country (2019-2024)

6.4.3 North America Liver Cancer Therapeutics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Liver Cancer Therapeutics Market Size (2019-2030)

7.2 Europe Liver Cancer Therapeutics Market Size by Type

7.2.1 Europe Liver Cancer Therapeutics Market Size by Type (2019-2024)

7.2.2 Europe Liver Cancer Therapeutics Market Size by Type (2025-2030)

7.2.3 Europe Liver Cancer Therapeutics Market Share by Type (2019-2030)

7.3 Europe Liver Cancer Therapeutics Market Size by Application

7.3.1 Europe Liver Cancer Therapeutics Market Size by Application (2019-2024)

7.3.2 Europe Liver Cancer Therapeutics Market Size by Application (2025-2030)

7.3.3 Europe Liver Cancer Therapeutics Market Share by Application (2019-2030)

7.4 Europe Liver Cancer Therapeutics Market Size by Country

7.4.1 Europe Liver Cancer Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Liver Cancer Therapeutics Market Size by Country (2019-2024)

7.4.3 Europe Liver Cancer Therapeutics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Liver Cancer Therapeutics Market Size (2019-2030)

8.2 China Liver Cancer Therapeutics Market Size by Type

8.2.1 China Liver Cancer Therapeutics Market Size by Type (2019-2024)

8.2.2 China Liver Cancer Therapeutics Market Size by Type (2025-2030)

8.2.3 China Liver Cancer Therapeutics Market Share by Type (2019-2030)

8.3 China Liver Cancer Therapeutics Market Size by Application

8.3.1 China Liver Cancer Therapeutics Market Size by Application (2019-2024)

8.3.2 China Liver Cancer Therapeutics Market Size by Application (2025-2030)

8.3.3 China Liver Cancer Therapeutics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Liver Cancer Therapeutics Market Size (2019-2030)

9.2 Asia Liver Cancer Therapeutics Market Size by Type

9.2.1 Asia Liver Cancer Therapeutics Market Size by Type (2019-2024)

9.2.2 Asia Liver Cancer Therapeutics Market Size by Type (2025-2030)

9.2.3 Asia Liver Cancer Therapeutics Market Share by Type (2019-2030)

9.3 Asia Liver Cancer Therapeutics Market Size by Application

9.3.1 Asia Liver Cancer Therapeutics Market Size by Application (2019-2024)

9.3.2 Asia Liver Cancer Therapeutics Market Size by Application (2025-2030)

9.3.3 Asia Liver Cancer Therapeutics Market Share by Application (2019-2030)

9.4 Asia Liver Cancer Therapeutics Market Size by Region

9.4.1 Asia Liver Cancer Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Liver Cancer Therapeutics Market Size by Region (2019-2024)

9.4.3 Asia Liver Cancer Therapeutics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 ArQule

11.1.1 ArQule Company Details

11.1.2 ArQule Business Overview

11.1.3 ArQule Liver Cancer Therapeutics Introduction

11.1.4 ArQule Revenue in Liver Cancer Therapeutics Business (2019-2024)

11.1.5 ArQule Recent Developments

11.2 Bayer

11.2.1 Bayer Company Details

11.2.2 Bayer Business Overview

11.2.3 Bayer Liver Cancer Therapeutics Introduction

11.2.4 Bayer Revenue in Liver Cancer Therapeutics Business (2019-2024)

11.2.5 Bayer Recent Developments

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Details

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Liver Cancer Therapeutics Introduction

11.3.4 Bristol-Myers Squibb Revenue in Liver Cancer Therapeutics Business (2019-2024)

11.3.5 Bristol-Myers Squibb Recent Developments

11.4 Celsion

11.4.1 Celsion Company Details

11.4.2 Celsion Business Overview

11.4.3 Celsion Liver Cancer Therapeutics Introduction

11.4.4 Celsion Revenue in Liver Cancer Therapeutics Business (2019-2024)

11.4.5 Celsion Recent Developments

11.5 Eisai

11.5.1 Eisai Company Details

11.5.2 Eisai Business Overview

11.5.3 Eisai Liver Cancer Therapeutics Introduction

11.5.4 Eisai Revenue in Liver Cancer Therapeutics Business (2019-2024)

11.5.5 Eisai Recent Developments

11.6 Exelixis

11.6.1 Exelixis Company Details

11.6.2 Exelixis Business Overview

11.6.3 Exelixis Liver Cancer Therapeutics Introduction

11.6.4 Exelixis Revenue in Liver Cancer Therapeutics Business (2019-2024)

11.6.5 Exelixis Recent Developments

11.7 Roche

11.7.1 Roche Company Details

11.7.2 Roche Business Overview

11.7.3 Roche Liver Cancer Therapeutics Introduction

11.7.4 Roche Revenue in Liver Cancer Therapeutics Business (2019-2024)

11.7.5 Roche Recent Developments

11.8 Merck

11.8.1 Merck Company Details

11.8.2 Merck Business Overview

11.8.3 Merck Liver Cancer Therapeutics Introduction

11.8.4 Merck Revenue in Liver Cancer Therapeutics Business (2019-2024)

11.8.5 Merck Recent Developments

11.9 Pfizer

11.9.1 Pfizer Company Details

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Liver Cancer Therapeutics Introduction

11.9.4 Pfizer Revenue in Liver Cancer Therapeutics Business (2019-2024)

11.9.5 Pfizer Recent Developments

11.10 IntegraGen

11.10.1 IntegraGen Company Details

11.10.2 IntegraGen Business Overview

11.10.3 IntegraGen Liver Cancer Therapeutics Introduction

11.10.4 IntegraGen Revenue in Liver Cancer Therapeutics Business (2019-2024)

11.10.5 IntegraGen Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

ArQule Inc

Bayer

Bristol–Myers Squibb

CELSION

Eisai Co Ltd

Exelixis Inc

Roche

Merck

Pfizer Inc

IntegraGen

List of Tables

Table 1. Global Liver Cancer Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Targeted Therapy

Table 3. Key Players of Radiation Therapy

Table 4. Key Players of Immunotherapy

Table 5. Key Players of Chemotherapy

Table 6. Key Players of Other

Table 7. Global Liver Cancer Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 8. Global Liver Cancer Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Liver Cancer Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Liver Cancer Therapeutics Market Share by Region (2019-2024)

Table 11. Global Liver Cancer Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Liver Cancer Therapeutics Market Share by Region (2025-2030)

Table 13. Liver Cancer Therapeutics Market Trends

Table 14. Liver Cancer Therapeutics Market Drivers

Table 15. Liver Cancer Therapeutics Market Challenges

Table 16. Liver Cancer Therapeutics Market Restraints

Table 17. Global Liver Cancer Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Liver Cancer Therapeutics Revenue Share by Players (2019-2024)

Table 19. Global Top Liver Cancer Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Therapeutics as of 2023)

Table 20. Global Liver Cancer Therapeutics Industry Ranking 2022 VS 2023 VS 2024

Table 21. Global 5 Largest Players Market Share by Liver Cancer Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Liver Cancer Therapeutics, Headquarters and Area Served

Table 23. Global Key Players of Liver Cancer Therapeutics, Product and Application

Table 24. Global Key Players of Liver Cancer Therapeutics, Product and Application

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Liver Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Liver Cancer Therapeutics Revenue Market Share by Type (2019-2024)

Table 28. Global Liver Cancer Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Liver Cancer Therapeutics Revenue Market Share by Type (2025-2030)

Table 30. Global Liver Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Liver Cancer Therapeutics Revenue Share by Application (2019-2024)

Table 32. Global Liver Cancer Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Liver Cancer Therapeutics Revenue Share by Application (2025-2030)

Table 34. North America Liver Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 35. North America Liver Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 36. North America Liver Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 37. North America Liver Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 38. North America Liver Cancer Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Liver Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Liver Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Liver Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 42. Europe Liver Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 43. Europe Liver Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 44. Europe Liver Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 45. Europe Liver Cancer Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Europe Liver Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 47. Europe Liver Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 48. China Liver Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 49. China Liver Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 50. China Liver Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 51. China Liver Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 52. Asia Liver Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 53. Asia Liver Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 54. Asia Liver Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 55. Asia Liver Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 56. Asia Liver Cancer Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 57. Asia Liver Cancer Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 58. Asia Liver Cancer Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Liver Cancer Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 64. Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 66. ArQule Company Details

Table 67. ArQule Business Overview

Table 68. ArQule Liver Cancer Therapeutics Product

Table 69. ArQule Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 70. ArQule Recent Developments

Table 71. Bayer Company Details

Table 72. Bayer Business Overview

Table 73. Bayer Liver Cancer Therapeutics Product

Table 74. Bayer Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 75. Bayer Recent Developments

Table 76. Bristol-Myers Squibb Company Details

Table 77. Bristol-Myers Squibb Business Overview

Table 78. Bristol-Myers Squibb Liver Cancer Therapeutics Product

Table 79. Bristol-Myers Squibb Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 80. Bristol-Myers Squibb Recent Developments

Table 81. Celsion Company Details

Table 82. Celsion Business Overview

Table 83. Celsion Liver Cancer Therapeutics Product

Table 84. Celsion Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 85. Celsion Recent Developments

Table 86. Eisai Company Details

Table 87. Eisai Business Overview

Table 88. Eisai Liver Cancer Therapeutics Product

Table 89. Eisai Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 90. Eisai Recent Developments

Table 91. Exelixis Company Details

Table 92. Exelixis Business Overview

Table 93. Exelixis Liver Cancer Therapeutics Product

Table 94. Exelixis Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 95. Exelixis Recent Developments

Table 96. Roche Company Details

Table 97. Roche Business Overview

Table 98. Roche Liver Cancer Therapeutics Product

Table 99. Roche Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 100. Roche Recent Developments

Table 101. Merck Company Details

Table 102. Merck Business Overview

Table 103. Merck Liver Cancer Therapeutics Product

Table 104. Merck Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 105. Merck Recent Developments

Table 106. Pfizer Company Details

Table 107. Pfizer Business Overview

Table 108. Pfizer Liver Cancer Therapeutics Product

Table 109. Pfizer Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 110. Pfizer Recent Developments

Table 111. IntegraGen Company Details

Table 112. IntegraGen Business Overview

Table 113. IntegraGen Liver Cancer Therapeutics Product

Table 114. IntegraGen Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 115. IntegraGen Recent Developments

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Liver Cancer Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Liver Cancer Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Targeted Therapy Features

Figure 4. Radiation Therapy Features

Figure 5. Immunotherapy Features

Figure 6. Chemotherapy Features

Figure 7. Other Features

Figure 8. Global Liver Cancer Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Liver Cancer Therapeutics Market Share by Application: 2023 VS 2030

Figure 10. Hepatocellular Carcinoma Case Studies

Figure 11. Cholangio Carcinoma Case Studies

Figure 12. Hepatoblastoma Case Studies

Figure 13. Other Case Studies

Figure 14. Liver Cancer Therapeutics Report Years Considered

Figure 15. Global Liver Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Liver Cancer Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Liver Cancer Therapeutics Market Share by Region: 2023 VS 2030

Figure 18. Global Liver Cancer Therapeutics Market Share by Players in 2023

Figure 19. Global Top Liver Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Therapeutics as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Liver Cancer Therapeutics Revenue in 2023

Figure 21. North America Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Liver Cancer Therapeutics Market Share by Type (2019-2030)

Figure 23. North America Liver Cancer Therapeutics Market Share by Application (2019-2030)

Figure 24. North America Liver Cancer Therapeutics Market Share by Country (2019-2030)

Figure 25. United States Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Liver Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 28. Europe Liver Cancer Therapeutics Market Share by Type (2019-2030)

Figure 29. Europe Liver Cancer Therapeutics Market Share by Application (2019-2030)

Figure 30. Europe Liver Cancer Therapeutics Market Share by Country (2019-2030)

Figure 31. Germany Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. France Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. U.K. Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Italy Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Russia Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Nordic Countries Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. China Liver Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 38. China Liver Cancer Therapeutics Market Share by Type (2019-2030)

Figure 39. China Liver Cancer Therapeutics Market Share by Application (2019-2030)

Figure 40. Asia Liver Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 41. Asia Liver Cancer Therapeutics Market Share by Type (2019-2030)

Figure 42. Asia Liver Cancer Therapeutics Market Share by Application (2019-2030)

Figure 43. Asia Liver Cancer Therapeutics Market Share by Region (2019-2030)

Figure 44. Japan Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. South Korea Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. China Taiwan Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. India Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Australia Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Share by Type (2019-2030)

Figure 52. Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Share by Application (2019-2030)

Figure 53. Middle East, Africa, and Latin America Liver Cancer Therapeutics Market Share by Country (2019-2030)

Figure 54. Brazil Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Mexico Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Turkey Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Israel Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. GCC Countries Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. ArQule Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)

Figure 61. Bayer Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)

Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)

Figure 63. Celsion Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)

Figure 64. Eisai Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)

Figure 65. Exelixis Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)

Figure 66. Roche Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)

Figure 67. Merck Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)

Figure 68. Pfizer Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)

Figure 69. IntegraGen Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global HCC Biomarker Market Research Report 2024

Metastatic Cancer Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Liver Cancer Treatment Drug Market Research Report 2025

Liver Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alpha Fetoprotein AFP Biomarker Market Research Report 2024

Global Ischemic Hepatitis Treatment Market Insights Forecast to 2030

Global Esophageal Cancer Drugs Market Insights Forecast to 2030

Global Alcoholic Hepatitis Treatment Market Insights Forecast to 2030

Metastatic Breast Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hepatocellular Carcinoma Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Tumor Markers for Primary Liver Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liver Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bile Duct Cancer Therapeutics Market Insights Forecast to 2030

Global Blood Cancer Therapeutics Market Insights Forecast to 2030

Global Advanced Liver Cancer Treatment Drugs Market Research Report 2024

Global Metastatic Bones Cancer Medication Treatment Market Insights Forecast to 2030

Global Primary Biliary Cholangitis Therapeutics Market Insights Forecast to 2030

Global Biliary Tumor Market Insights Forecast to 2030

Global Metastatic Bones Cancer Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions